Feasibility study of early outpatient review and early cardiac rehabilitation after cardiac surgery: mixed-methods research design-a study protocol. by Ngaage, Dumbor et al.
Feasibility study of early outpatient review and early 
cardiac rehabilitation after cardiac surgery: mixed-
methods research design-a study protocol.
NGAAGE, Dumbor, MITCHELL, Natasha, DEAN, Alexandra, HIRST, Claire, 
AKOWUAH, Enoch, DOHERTY, Patrick Joseph <http://orcid.org/0000-0002-
1887-0237>, FAIRHURST, Caroline, FLEMMING, Kate, HEWITT, Catherine, 
HINDE, Sebastian <http://orcid.org/0000-0002-7117-4142>, MITCHELL, Alex, 
NICHOLS, Simon <http://orcid.org/0000-0003-0377-6982> and WATSON, 
Judith <http://orcid.org/0000-0003-0694-3854>
Available from Sheffield Hallam University Research Archive (SHURA) at:
http://shura.shu.ac.uk/25639/
This document is the author deposited version.  You are advised to consult the 
publisher's version if you wish to cite from it.
Published version
NGAAGE, Dumbor, MITCHELL, Natasha, DEAN, Alexandra, HIRST, Claire, 
AKOWUAH, Enoch, DOHERTY, Patrick Joseph, FAIRHURST, Caroline, FLEMMING, 
Kate, HEWITT, Catherine, HINDE, Sebastian, MITCHELL, Alex, NICHOLS, Simon 
and WATSON, Judith (2019). Feasibility study of early outpatient review and early 
cardiac rehabilitation after cardiac surgery: mixed-methods research design-a study 
protocol. BMJ Open, 9 (12), e035787. 
Copyright and re-use policy
See http://shura.shu.ac.uk/information.html
Sheffield Hallam University Research Archive
http://shura.shu.ac.uk
1Ngaage D, et al. BMJ Open 2019;9:e035787. doi:10.1136/bmjopen-2019-035787
Open access 
Feasibility study of early outpatient 
review and early cardiac rehabilitation 
after cardiac surgery: mixed- methods 
research design—a study protocol
Dumbor Ngaage,1 Natasha Mitchell,2 Alexandra Dean,2 Claire Hirst,2 
Enoch Akowuah,3 Patrick Joseph Doherty   ,4 Caroline Fairhurst,2 
Kate Flemming,4 Catherine Hewitt,2 Sebastian Hinde   ,5 Alex Mitchell,2 
Simon Nichols   ,6 Judith Watson   2
To cite: Ngaage D, Mitchell N, 
Dean A, et al.  Feasibility study 
of early outpatient review and 
early cardiac rehabilitation 
after cardiac surgery: mixed- 
methods research design—a 
study protocol. BMJ Open 
2019;9:e035787. doi:10.1136/
bmjopen-2019-035787
 ► Prepublication history and 
additional material for this 
paper are available online. To 
view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2019- 
035787).
Received 15 November 2019
Revised 28 November 2019
Accepted 02 December 2019
For numbered affiliations see 
end of article.
Correspondence to
Dumbor Ngaage;  
 dumbor. ngaage@ hey. nhs. uk
Protocol
© Author(s) (or their 
employer(s)) 2019. Re- use 
permitted under CC BY. 
Published by BMJ.
AbstrACt
Introduction Following cardiac surgery, patients currently 
attend an outpatient review 6 weeks after hospital 
discharge, where recovery is assessed and suitability to 
commence cardiac rehabilitation (CR) is determined. CR is 
then started from 8 weeks. Following a median sternotomy, 
cardiac surgery patients are required to refrain from 
upper body exercises, lifting of heavy objects and other 
strenuous activities for 12 weeks. A delay in starting CR 
can prolong the recovery process, increase dependence 
on family/carers and can cause frustration. However, 
current guidelines for activity and exercise after median 
sternotomy have been described as restrictive, anecdotal 
and increasingly at odds with modern clinical guidance for 
CR. This study aims to examine the feasibility of bringing 
forward outpatient review and starting CR earlier.
Methods and analyses This is a multicentre, randomised 
controlled, open feasibility trial comparing postoperative 
outpatient review 6 weeks after hospital discharge, 
followed by CR commencement from 8 weeks (control 
arm) versus, postoperative outpatient review 3 weeks after 
hospital discharge, followed by commencement of CR from 
4 weeks (intervention arm). The study aims to recruit 100 
eligible patients, aged 18–80 years who have undergone 
elective or urgent cardiac surgery involving a full median 
sternotomy, over a 7- month period across two centres. 
Feasibility will be measured by consent, recruitment, 
retention rates and attendance at appointments and CR 
sessions. Qualitative interviews with trial participants 
and staff will explore issues around study processes and 
acceptability of the intervention and the findings integrated 
with the feasibility trial outcomes to inform the design of a 
future full- scale randomised controlled trial.
Ethics and dissemination Ethics approval was granted 
by East Midlands—Derby Research Ethics Committee 
on 10 January 2019. The findings will be presented at 
relevant conferences disseminated via peer- reviewed 
research publications, and to relevant stakeholders.
trial registration number ISRCTN80441309
IntroduCtIon
Following cardiac surgery, patients currently 
attend their first outpatient review 6 weeks after 
hospital discharge, where recovery is assessed 
and ability to commence cardiac rehabilita-
tion (CR) is determined. CR is then started 
from 8 weeks. In a 2017 survey, 35 of the 42 
UK cardiac centres who responded, confirmed 
this as current practice.1 This interval before 
review and CR extends the period of inactivity 
of patients, and medical attention for surgery- 
related complications is often sought during 
this period.2–4 Our prospective observational 
study (FORCAST6) found that 39% of patients 
reported surgery- related complications in the 
6 weeks following discharge, with the majority 
occurring in the first 4 weeks; 15% required 
hospital readmission. Although the majority of 
patients were satisfied with the 6 weeks interval, 
44% felt it was too long and would have liked 
an earlier review.1
The standard access for heart operations is 
through a median sternotomy.5–8 In the UK, 
35 158 heart operations were performed in 
2015.9 Following a median sternotomy, patients 
are required to refrain from upper body exer-
cises, lifting of heavy objects and other strenuous 
strengths and limitations of this study
 ► This is one of the first studies to look at the timing 
of follow- up and cardiac rehabilitation after cardiac 
surgery.
 ► This feasibility study is a small multicentre ran-
domised controlled trial (RCT).
 ► The study will collect both qualitative and quanti-
tative data.
 ► If it is determined that a larger scale RCT is feasible, 
this study will generate valuable data to enable its 
design.
 ► This feasibility study is not large enough to deter-
mine effectiveness or cost- effectiveness and is lim-
ited to assessing the feasibility of a larger trial.
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activities for 12 weeks.10–13 These ‘sternal precautions’ (SP) 
are intended to aid healing of the sternum. CR, which has 
significant short- term and long- term benefits after cardiac 
surgery,14 15 is therefore delayed. The delay can mitigate the 
benefits of CR,16 contributing to physical deconditioning, 
and hinder the ability of CR to facilitate timely recovery 
of fitness and physical activity status.17 However, current 
guidelines for activity and exercise after median sternotomy 
have been described as restrictive, conflicting, sometimes 
arbitrary, frequently anecdotal and frequently at odds with 
modern clinical guidance.11
Following surgery, there are variations in types of exer-
cises permitted, limits for weight of objects that can be 
lifted, guidelines for activities and timeline for resump-
tion of driving. Parker et al18 demonstrated that the force 
elicited on the breastbone by coughing far exceeded 
lifting above the recommended limit. Adams et al11 inves-
tigated forces associated with 32 activities of daily living 
and reported that the majority not restricted by SP, such 
as opening and closing doors, generated forces greater 
than the allowed weight limit. While SP may help to 
support bone healing, the optimal nature and duration 
are unclear especially since sternal bone healing occurs 
by 5 weeks.12 According to the 2013 UK national audit 
of CR, late commencement contributes to a substantial 
number of heart surgery patients declining to partici-
pate.19 Adverse outcomes following heart operations and 
other forms of surgery have been shown to be reduced 
by early patient review after hospital discharge.20 21 The 
FORCAST6 study showed a high incidence of postopera-
tive complications with the current 6- week patient review 
after heart surgery. This was the highest in the first week 
after hospital discharge and declined to lowest levels by 
4 weeks.1 It, therefore, seems logical to conduct patient 
reviews after hospital discharge sooner than current prac-
tice to enable early CR from the period of postoperative 
stability and sternal bone healing at 5 weeks after surgery 
(4 weeks after hospital discharge).
The British Association for Cardiovascular Prevention 
and Rehabilitation (BACPR) Standards and Core Compo-
nents22 and the National Certification Programme for 
CR23 recommend early commencement of CR. This is 
monitored by the National Audit of CR 2018.19 A delay 
in starting CR can prolong the recovery process, increase 
dependence on family/carers and can cause frustration. 
This may contribute to anxiety and depression that is 
reported in patients recovering after cardiac surgery.24
This study aims to examine the feasibility of bringing 
forward outpatient review and CR in order to facilitate 
recovery, physical fitness and quality of life.
MEthods And AnAlysIs
study design
A multicentre, randomised controlled, open feasibility 
trial using mixed methods to establish the feasibility of 
conducting a study where:
 ► Participants have a postoperative outpatient review 6 
weeks after hospital discharge, followed by commence-
ment of CR from 8 weeks (control arm) or
 ► Participants have a postoperative outpatient review 3 
weeks after hospital discharge, followed by commence-
ment of CR from 4 weeks (intervention arm).
The study is detailed in figure 1: study flow chart 
and the protocol follows the Standard Protocol Items: 
Recommendations for Interventional Trials reporting 
guidelines.25
study aim
To establish the feasibility of delivering and evaluating 
a definitive randomised controlled trial (RCT) of the 
current 8th vs 4th week CR commencement pathways, 
reducing the period over which patients are required to 
refrain from usual physical activities following cardiac 
surgery.
study objectives
The primary objective is to determine the feasibility of 
delivering outpatient review 3 weeks after discharge post-
cardiac surgery, followed by CR from 4 weeks.
Secondary objectives
 ► Assess surgeons’ and surgical practitioners’ willingness 
to conduct outpatient review 3 weeks after discharge 
and refer patients to CR.
 ► Examine barriers to patient enrolment.
 ► Identify recruitment rates and drop- out to follow- up.
 ► Identify the most appropriate outcome measures.
 ► Test follow- up procedures and data collection tools 
and management.
 ► Assess the feasibility of conducting an economic eval-
uation of any future definitive RCT.
 ► Gather outcome data for power and sample size calcu-
lations for the RCT.
 ► Inform any necessary redesign of a new recovery 
pathway in light of information gained.
study population and setting
Patients attending for cardiac surgery at Hull University 
Teaching Hospitals National Health Service (NHS) Trust, 
UK and South Tees Hospitals NHS Foundation Trust, UK 
will be approached regarding study participation.
Inclusion criteria
 ► Undergone elective or urgent cardiac surgery, 
including the following procedures (isolated or 
combined):
 – Coronary artery bypass graft (CABG).
 – Aortic valve replacement.
 – Mitral valve repair or replacement.
 – Atrial fibrillation ablation.
 – Left atrial appendage occlusion.
 ► Has had a full median sternotomy.
 ► Willing and capable of giving informed consent.
 ► Aged 18–80 years at the time of giving consent.
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Figure 1 FARSTER study flow chart. PIS, Patient Information Sheet.
 ► Able to self- complete the English language outcome 
measure tools (or can complete with assistance).
 ► Able to follow detailed verbal instructions required 
for clinical assessments.
Exclusion criteria
 ► Body mass index (BMI) >45 kg/m2.
 ► Heart failure with left ventricular ejection fraction of 
<30% before surgery.
 ► Early postoperative sternal wound complications (eg, 
deep sternal wound infection, wound dehiscence 
and/or sternal instability).
 ► Postoperative complications resulting in prolonged 
hospital stay >14 days after surgery.
Amendment to eligibility criteria
During the initial recruitment period, fewer patients than 
anticipated were meeting the eligibility criteria, and many 
were ‘out of area’ impacting on their ability to attend 
study CR locations. With the funder’s approval, a substan-
tial amendment was submitted to the ethics committee. 
The original criteria had only included patients who had 
undergone CABG, had an upper age limit of 75 years and 
a maximum BMI limit of 40 kg/m2. This amendment was 
approved on 30 October 2019.
sample size
This study is a feasibility RCT and therefore does not 
have a primary outcome measure to inform a power 
calculation. Sample sizes of between 24 and 70 have been 
recommended for feasibility trials to allow for the reliable 
estimation of an SD for use in future sample size calcu-
lations.26 27 The plan is to recruit 100 eligible patients, 
allowing for a 30% attrition rate in order to still have 
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70 patients in the final analysis. There will be a 7- month 
recruitment period across two centres.
Participant recruitment
Patients scheduled for elective cardiac surgery will be 
given the study leaflet prior to surgery. Patients under-
going urgent cardiac surgery will receive it following 
surgery. All patients will undergo surgery as normal, 
receiving standard in- hospital postoperative care.
Eligibility and consent
After discharge from intensive care to the ward following 
surgery, the medical staff will review patients’ routine 
clinical examination results, including sternal stability 
and postoperative tests. Those identified as potentially 
eligible, interested and willing, will have their eligibility 
confirmed by the research nurse using an eligibility 
checklist and written informed consent will be obtained 
according to Good Clinical Practice guidelines. Consent 
will also be sought to contact participants who are inter-
ested in being interviewed as part of an embedded qual-
itative study.
Patients screened as eligible, but who develop complica-
tions between being considered ready for discharge and 
going home, will not proceed to consent until deemed 
well enough (if remain in hospital for >14 days after 
surgery, as per exclusion criteria they will not proceed at 
all).
randomisation
Following surgery, consent and completion of baseline 
data collection and assessments, participants will be 
randomised to either the control or intervention arm.
Randomisation will be performed by a remote, 
centralised randomisation service provided by York Trials 
Unit (YTU), and the allocation sequence generated by 
a statistician not involved in the study. Participants will 
be individually randomised and stratified according to 
study site on a 1:1 basis using variable block sizes. Autho-
rised site research staff will telephone the randomisation 
service to obtain the participant’s allocation.
outcomes
Participant self- reported data will be collected at base-
line, prior to CR commencement, following CR comple-
tion and at final follow- up assessment (up to 26 weeks 
postrandomisation):
1. Demographics (baseline only).
2. EQ- 5D- 5L (EuroQol-5 dimensions-5 levels): a validated 
generic patient- reported outcome measure.28
3. NHS resource use.
The following clinical data will be collected:
1. Height, weight, BMI, preoperative presentation (base-
line only).
2. Heart rate, blood pressure, oxygen saturation at base-
line, outpatient review and pre- CR as per usual prac-
tice.
3. Physical fitness assessed by dynamic testing with incre-
mental shuttle walk test (ISWT) for both study arms at 
commencement and end of CR, and at final follow- up.
4. Cardiopulmonary fitness assessed by cardiopulmonary 
exercise testing (CPET) at baseline and at final follow- 
up, for up to 25 patients in each study arm (Hull study 
site only).
5. 30 and 90- day mortality, surgical site complications and 
hospital readmission rates.
In line with the objectives of a feasibility study, we will 
also gather information on:
6. Recruitment rates and drop- out to follow- up.
7. Compliance to treatment arm allocation.
8. Acceptability of patient recruitment, early outpa-
tient review and CR to patients, clinicians and NHS 
organisations.
Cardiopulmonary exercise testing
Maximal CPET provides a holistic assessment of the 
cardiovascular, ventilatory and metabolic responses to 
exercise and is a powerful diagnostic and prognostic 
tool.29 Maximal CPET is the gold- standard method of 
assessing changes in aerobic fitness, which is potentially 
important if we are to assess the beneficial/not harmful 
effects of early CR. Maximal CPET will be conducted on 
a cycle ergometer with patients pedalling at 50 revolu-
tions per minute throughout the test. The test workload 
will start at 0watts and increase in 10watts/minute incre-
ments until the patient reaches volitional exhaustion 
(ideally 8–12 min29). Maximal CPET will only be carried 
out (after randomisation) in up to 25 participants in 
each arm in the Hull site only due to costs and logistics, 
but also to ensure that test procedures and data inter-
pretation are consistent. CPET will be completed once 
a participant is deemed clinically stable and conducted 
within 14 days after surgery. It will be repeated at the 
final follow- up.
Postoperative outpatient review
As standard practice, all participants will have a postop-
erative outpatient clinical review in order to be certi-
fied suitable to commence CR. This clinical decision 
is usually based on the absence of limiting complica-
tions. This review will take place at 6 weeks posthospital 
discharge in the control arm, and 3 weeks postdischarge 
in the intervention arm. Participants considered unfit 
for CR will be given a second review appointment for 
approximately 1 week later and if necessary, a third 
review appointment 2 weeks later. Reason(s) they were 
deemed unfit will be documented. If they are deemed 
unfit for CR at the third review, they will not commence 
CR as part of the Feasibility Study of Early Outpatient 
Review and Early Cardiac Rehabilitation After Cardiac 
Surgery: Mixed Methods Research Design (FARSTER) 
study. They will, however, continue to be monitored as 
per usual practice and be sent all study questionnaires 
for completion.
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Pre-Cr assessment
Referred participants will be offered a comprehensive 
programme and an assessment prior to starting their 
programme. Participants will receive a holistic assessment 
from a specialist physiotherapist or exercise professional 
including exercise testing using the ISWT to help person-
alise their exercise prescription. The ISWT is a popular 
aerobic fitness assessment tool in UK CR programmes 
and recommended by the CR physiotherapist associa-
tion.30 31 Although reference values for ISWT are avail-
able in conventional CR patient populations,32 they have 
not yet been validated for use in the early CR cohorts. If 
a participant misses this appointment, they will be sent 
another.
Cr programme
This will consist of supervised low- to- moderate intensity 
exercise performed once (South Tees) or twice (Hull) 
a week for 8 weeks (as is standard UK practice). Exer-
cise will be prescribed according to standards published 
by BACPR.22 Attendance at these sessions and session 
content will be recorded for each participant.
Post-Cr appointment
Following completion of the CR programme (16 weeks 
postdischarge for the control arm and 12 weeks postdis-
charge for the intervention arm), all participants will 
have a repeat ISWT. If a participant misses this appoint-
ment, they will be sent another. A discharge letter will be 
sent to participants’ general practitioners summarising 
their treatment.
Final follow-up assessment
At final follow- up (up to 26 weeks after randomisation), 
participants will have a repeat CPET (if appropriate), 
undergo a final ISWT, have an end- of- study consulta-
tion and be examined for sternal wound complications, 
including sternal instability. Medical history will be taken 
to establish hospital readmissions and accident & emer-
gency department attendance for surgery- related compli-
cations. If a participant misses this appointment, they will 
be sent another.
data collection
At pre- CR and post- CR appointments and the final 
follow- up assessment, participants will be asked to 
complete quality of life (EQ- 5D- 5L) and resource use 
questions (see table 1). If a participant does not attend, 
the questionnaire will be posted out to them, with two 
reminders subsequently sent if no response (1 and 2 weeks 
later as necessary).
Qualitative data collection
After the outpatient review, we will conduct semistruc-
tured interviews by telephone with approximately 10 
participants from each treatment arm (20 in total) to 
determine their views on the timing of their postopera-
tive outpatient review and readiness to commence CR. 
These participants will be purposively selected from those 
who agreed to be approached for interview. A second 
interview will be held with the same participants on their 
completion of the study to determine their views on the 
timing of the outpatient review and CR, study conduct 
and processes. All interviews will be digitally recorded 
with participant permission.
Participants will be encouraged to complete bespoke 
CR diaries for the 8 weeks of CR detailing their experi-
ence at each session, including willingness to take part 
and any difficulties.
Research nurses will complete a diary detailing recruit-
ment of patients, reasons for non- consent and any diffi-
culties encountered with patient follow- up. CR staff will 
be asked to keep a diary collecting information about 
participant drop- outs/opt- outs, level of participation 
and adverse events (AEs) during the sessions. In addi-
tion, staff involved in the research will be invited a focus 
group at the end of final follow- up to discuss any diffi-
culties encountered with recruitment, outpatient review, 
CR sessions and follow- up. Organisational and clinical 
barriers will also be examined.
Data will be analysed separately for patients, research 
staff and clinical staff using conventional content anal-
ysis.33 Transcribed data from the interviews and focus 
groups will be downloaded into qualitative data analysis 
computer software package, coded and analysed induc-
tively using thematic content analysis34 to inform the 
development of the logistical processes involved in deliv-
ering a large- scale multicentre RCT.
statistical analyses
A full statistical analysis plan detailing intended analyses 
will be drafted before completion of data collection. Anal-
ysis and reporting will follow Consolidated Standards 
of Reporting Trials guidelines35 36 and a flow diagram 
will depict the progression of participants through the 
trial. Baseline data will be summarised by randomised 
group with no formal statistical comparisons under-
taken. Continuous variables will be summarised using 
descriptive statistics (n, mean, SD, median, minimum 
and maximum) while categorical data will be reported 
as counts and percentages. Participant outcomes will be 
summarised descriptively by randomised group and time 
point, including extent of missing data. As this is a feasi-
bility trial, formal hypothesis testing for effectiveness will 
not be carried out. The number of participants attending 
their review appointment and entering CR, and the time 
between surgery and these events, will be summarised 
by treatment group. Questionnaire return rates will be 
presented and AEs will be summarised descriptively. No 
interim analyses will be conducted.
health economics analysis
A full cost- effectiveness analysis will not be undertaken 
as part of this feasibility study. Instead, the study will 
consider the feasibility of collecting the data needed for an 
economic analysis of a full- scale trial and explore the rate 
of response and missingness of relevant questionnaires. 
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Estimates of patient benefit, determined from the 
EQ- 5D- 5L, and NHS resource use, using patient reported 
questionnaires, will be summarised for the two arms of 
the trial. Mortality and AE rates will also be monitored 
to determine the importance of long- term extrapolation 
of related outcomes for any future analysis of a full- scale 
RCT. As this is a feasibility trial, formal estimation of the 
cost- effectiveness of the respective interventions will not 
be carried out.
blinding
By the nature of the timing of the study treatments, 
blinding of the participants and clinicians is not possible 
and a procedure for unblinding is not necessary. The 
clinician evaluating the CPET data will be blinded. The 
statistician and health economist will be blinded to study 
allocation.
safety measurements
AEs and serious AEs (SAEs) will be recorded throughout 
the study. Intensity and relationship to the study interven-
tion will be described. Examples of AE related to partic-
ipation in this study would be: atrial fibrillation, sternal 
pain and undue fatigue or exhaustion. An example of an 
SAE would be sternal instability.
Participants will undergo clinical assessment after 
discharge and be certified suitable for CR by the surgical 
team. Before commencing CR, they will undergo exercise 
testing, and CR will be tailored to their fitness levels. At 
completion of CR, they will have another assessment and 
exit consultation.
Information about AEs whether patient reported, 
discovered via clinical team questioning, identified 
through physical examination or in medical notes, will be 
recorded up to and including final follow- up. Ongoing 
review of AEs will take place during monthly trial manage-
ment group (TMG) meetings, discussed with the patient 
advisory group (PAG) and trial steering committee 
(TSC) and reported to the sponsor and research ethics 
committee in line with their guidelines.
data collection, integrity and management
Data collected as part of this research includes question-
naires, clinical assessments, information from medical 
records and qualitative data from interviews. Data will 
be collected through designed questionnaires identified 
by a unique participant trial number only. Each site will 
hold data according to the current Data Protection Act 
(2018)37 and the General Data Protection Regulation 
(May 2018).38
All information collected during the study will be kept 
strictly confidential and stored on a secure password- 
protected server located at the University of York, for 
the purposes of assisting in follow- ups during the study. 
All paper documents will be stored securely. Electronic 
sound files and transcripts from qualitative interviews will 
be assigned a unique participant number, known only to 
the qualitative researcher and appropriate members of 
the research team. Any quotes published will be anony-
mous. All data will be archived for 10 years following the 
end of the study.
Patient and public involvement
A PAG will hold meetings with research nurses, CR staff 
and sites’ principal investigators during the study to 
discuss any challenges encountered and how to overcome 
them. The group act as an important source of reference 
and the research progress will be discussed. Their role 
initially included assisting with the development of study 
documentation ensuring material was clear to the lay 
public; identifying barriers to participation and possible 
mitigation of those barriers; and providing input for topic 
guides for the qualitative research. Towards completion of 
the study, the PAG will identify appropriate pathways for 
dissemination and contribute to writing the lay summary.
EthICs, ovErsIght And dIssEMInAtIon
The TMG, led by the chief investigator, are responsible 
for overseeing the day- to- day running and management 
of the trial with YTU responsible for project manage-
ment. Due to the low- risk nature of this trial, one inde-
pendent steering and monitoring committee will fulfil 
the roles traditionally undertaken by the TSC and data 
monitoring committee. It will comprise of a chair, statisti-
cian, one other independent member and public involve-
ment representative.
Study findings will be discussed with participants, 
PAG, and at a meeting of local general practitioners. 
Study results will be presented at annual conferences of 
The Society for Cardiothoracic Surgery of Great Britain 
and Ireland, BACPR and The European Association 
for Cardiothoracic Surgery. Study results will also be 
submitted to the funders and peer- reviewed journals.
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